PredictImmune

PredictImmune is developing pioneering tools to guide treatment choices for immune-mediated inflammatory diseases, with its first product addressing inflammatory bowel disease (Crohn's disease and ulcerative colitis). Based on world-leading research from the University of Cambridge, UK, they are developing a simple laboratory test using a small blood sample to accurately identify patients at diagnosis who are likely to develop severe, recurrent disease. These patients may benefit from early biologic therapy. Physicians, patients, and payers all recognize the value of this approach in managing inflammatory bowel disease.